Choline bitartrate is an active pharmaceutical ingredient produced from a mixture of tartaric acid and choline. It has a better absorption rate than pure choline and is widely available in two different types such choline l-bitartrate and choline dl-bitartrate. It plays a crucial role in lipid transportation, healthy metabolism, supports cell membrane, DNA synthesis, and early brain development. It is utilized in producing organic and fortified organic baby foods as they enhance visuospatial memory in a child. It is used in various health-related problem and is widely used in poultry and animal feed, baby food, pharmaceutical & nutritional supplement, and food & beverage.
In recent years, there is rising demand for infant formula due to the surge in the baby boomers population, rapid urbanization, rising disposable income of people in developing countries, and increasing female participation in the labor force. According to Vitafoods Insights, infant formula sales is predicted to witness substantial growth via e-commerce, and starting milk formulas are anticipated to hold around 45% of global demand. Infant formula sales will continue to grow due to its growing acceptance as a viable breastmilk alternative. Further, during 2019-2026, the global infant formula market is projected for noteworthy growth at a 10% CAGR. Moreover, according to Agricultural Marketing Service U.S. DEPARTMENT OF AGRICULTURE (AMS USDA), choline salts are allowable in infant formula in Canada, listed under Division 25 (B.25.054(1)(a)(vii)) of the Food and Drug Regulations. Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to Organic Production Systems General Principles and Management Standards (CAN/CGSB‐32.310‐2006) and Organic Production Systems Permitted Substances List (CAN/CGSB‐32.311‐2006). Further, choline salts are an acceptable form of choline in infant formula and baby food in European Union, according to Commission Directive 2006/141/EC, Commission Directive 2006/125/EC. They are also allowed in the category of “foods for particular nutritional uses” (Commission Regulation 953/2009, Commission Directive 2009/39/EC). Choline salts are allowable in organic counterparts of these food products by virtue of their necessity by legal requirement, according to European Commission Regulation 889/2008. Thus, the growing demand for infant formula is anticipated to propel the demand for choline bitartrate during the forecast period. However, growing inclination towards natural food products and stringent regulation for manufacturing infant formula may hamper the steady growth of the market. Nonetheless, the growing use of choline bitartrate in healthcare to treat numerous diseases and its use in poultry and animal feed is anticipated to create lucrative opportunities for the growth of the choline bitartrate market.
The choline bitartrate market is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products. Further, the rise in sales of dietary supplements owing to the hectic routines and stress level of the consumers is anticipated to propel the choline bitartrate market growth during the forecast period.
The key players operating in the global choline bitartrate market include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co.,Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co.,Ltd; NutriScience Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. These companies compete for the share of the market through product launch, joint venture, partnership, and expansion of the production capabilities to meet the future demand for the choline bitartrate market during the forecast period.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the choline bitartrate market analysis from 2021 to 2031 to identify the prevailing choline bitartrate market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the choline bitartrate market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global choline bitartrate market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Type
- DL
- D
- L
By Application
- Baby Food
- Others
- Pharmaceutical and Nutritional Supplement
- Food and beverage
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Spain
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia-Pacific
- LAMEA
- Rest of LAMEA
- Brazil
- Saudi Arabia
- South Africa
Key Market Players
- Balchem Inc.
- Celtic Chemicals Ltd
- Cepham Life Sciences
- Fengchen Group Co.,Ltd
- Glentham Life Sciences Ltd
- MP Biomedicals
- Nutragreenlife Biotechnology Co.,Ltd
- NutriScience Innovations, LLC
- Puyer Group
- TOKYO CHEMICAL INDUSTRY CO., LTD.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
Executive Summary
According to the report, titled, “Choline bitartrate Market," the choline bitartrate market was valued at $410.2 million in 2021, and is estimated to reach $736.2 million by 2031, growing at a CAGR of 6.1% from 2022 to 2031.Choline bitartrate is utilized in the different wellbeing-related issues. It is primarily utilized in dietary supplements. Choline supplements are used to lower cholesterol, reduce mood swings, and protect the liver from alcohol damage. Besides, choline bitartrate can also lower blood pressure, improve memory and treat Alzheimer's disease. Choline can also improve athletic performance and helps prevent neural tube defects during pregnancy. Its acceptance in the infant dietary food, supplementary dietary foods, foods & beverages industry will drive the market demand. Rising awareness regarding essential nutrition and growing emphasis on preventive health care will propel the demand for choline bitartrate in upcoming years.
The choline bitartrate industry is classified into type, application, and region. On the basis of type, the market is segmented into DL, D, and L. On the basis of application, the market is divided into pharmaceutical & nutritional supplement, food & beverage, baby food, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. Among the regions, North America held the highest share of the global choline bitartrate market in 2021 owing to increase in demand for baby food and infant formula products.
The key players included in the report include Balchem Inc.; Celtic Chemicals Ltd; Cepham Life Sciences; Fengchen Group Co., Ltd; Glentham Life Sciences Ltd; MP Biomedicals; Nutragreenlife Biotechnology Co., Ltd; NutriSciences Innovations, LLC; Puyer Group; and TOKYO CHEMICAL INDUSTRY CO., LTD. Other players in the value chain of the choline bitartrate market include Arochem, SALVI CHEMICAL INDUSTRIES LTD., Acros Organics BVBA, Aurora Fine Chemicals LLC, Finetech Industry Limited, AHH Chemical co., ltd, abcr GmbH, AK Scientific Inc.
COVID-19 Analysis
The COVID-19 pandemic has had extraordinary consequences on the choline bitartrate market's end-use industries. It also has an influence on the supply of active materials and ingredients (mostly from China), as well as the import and export of pharmaceutical products, where demand has increased to strengthen people's immunity. Physical barriers, such as the skin and gut epithelium, are part of the innate immune system and assist prevent pathogen entrance. It also comprises leukocytes (white blood cells) that try to locate and eradicate invading infections, such as neutrophils, macrophages (which release cytokines), and natural killer cells. However, health concerns were not taken seriously before the COVID-19 outbreak. Due to the COVID-19 outbreak, the health awareness among the populace has grown and the pharmaceutical sector has benefited from dietary supplements. The growing demand for dietary supplements is predicted to drive the market for choline bitartrate globally during the COVID-19 pandemic.Key Findings of the Study
- By region, North America accounted for the largest global choline bitartrate market share in 2021.
- By type, the L segment is projected to grow at the highest CAGR during the choline bitartrate market forecast period.
- By application, the pharmaceutical & nutritional supplement segment is expected to dominate the global choline bitartrate market during the forecast period.
Companies Mentioned
- Balchem Inc.
- Celtic Chemicals Ltd
- Cepham Life Sciences
- Fengchen Group Co.Ltd
- Glentham Life Sciences Ltd
- Mp Biomedicals
- Nutragreenlife Biotechnology Co.Ltd
- Nutriscience Innovations, LLC
- Puyer Group
- Tokyo Chemical Industry Co. Ltd.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 255 |
Published | June 2022 |
Forecast Period | 2021 - 2031 |
Estimated Market Value ( USD | $ 410.2 million |
Forecasted Market Value ( USD | $ 736.2 million |
Compound Annual Growth Rate | 6.0% |
Regions Covered | Global |
No. of Companies Mentioned | 10 |